- Chromosome 9
Upload your DNA to see your personal genotypes for variants in -.
What This Gene Does
"Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome"
Associated Conditions (25)
Levothyroxine response
Statins
attenuated cholesterol lowering by
Chronic obstructive pulmonary disease
Familial prostate cancer
Chronic osteomyelitis
Venous thromboembolism
Radial aplasia-thrombocytopenia syndrome
GPR89B-related condition
Sudden infant death-dysgenesis of the testes syndrome
Choroideremia
Delayed puberty
Intestinal malrotation
Hypogonadotropic hypogonadism 5 with or without anosmia
Autosomal recessive osteopetrosis 7
46
XY sex reversal 1
CHARGE syndrome
Complex cortical dysplasia with other brain malformations 1
XG BLOOD GROUP SYSTEM
+5 more conditions
Key Variants
RS11185644
drug response
Levothyroxine response, Levothyroxine response
Drug Response
RS2073547
drug response
Statins, attenuated cholesterol lowering by, Statins
Drug Response
RS4629571
drug response
Statins, attenuated cholesterol lowering by, Statins
Drug Response
RS10836312
association
Chronic obstructive pulmonary disease, Chronic obstructive pulmonary disease
Health Risk
RS188140481
association
Familial prostate cancer, Familial prostate cancer
Health Risk
RS398652
association
Chronic osteomyelitis, Chronic osteomyelitis
Health Risk
RS7675998
association
Chronic osteomyelitis, Chronic osteomyelitis
Health Risk
RS906902
association
Chronic obstructive pulmonary disease, Chronic obstructive pulmonary disease
Health Risk
RS2853513
association not found
Venous thromboembolism, Venous thromboembolism
Health Risk
RS61746197
Conflicting classifications of pathogenicity
Radial aplasia-thrombocytopenia syndrome, GPR89B-related condition, Radial aplasia-thrombocytopenia syndrome
Health Risk
RS2088000353
Likely pathogenic
Sudden infant death-dysgenesis of the testes syndrome, Sudden infant death-dysgenesis of the testes syndrome, Sudden infant death-dysgenesis of the testes syndrome
Health Risk
RS2147819369
Likely pathogenic
Choroideremia, Choroideremia
Health Risk
All Variants (29)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS11185644 | Drug Response | drug response | Levothyroxine response, Levothyroxine response |
| RS2073547 | Drug Response | drug response | Statins, attenuated cholesterol lowering by, Statins |
| RS4629571 | Drug Response | drug response | Statins, attenuated cholesterol lowering by, Statins |
| RS10836312 | Health Risk | association | Chronic obstructive pulmonary disease, Chronic obstructive pulmonary disease |
| RS188140481 | Health Risk | association | Familial prostate cancer, Familial prostate cancer |
| RS398652 | Health Risk | association | Chronic osteomyelitis, Chronic osteomyelitis |
| RS7675998 | Health Risk | association | Chronic osteomyelitis, Chronic osteomyelitis |
| RS906902 | Health Risk | association | Chronic obstructive pulmonary disease, Chronic obstructive pulmonary disease |
| RS2853513 | Health Risk | association not found | Venous thromboembolism, Venous thromboembolism |
| RS61746197 | Health Risk | Conflicting classifications of pathogenicity | Radial aplasia-thrombocytopenia syndrome, GPR89B-related condition, Radial aplasia-thrombocytopenia syndrome |
| RS2088000353 | Health Risk | Likely pathogenic | Sudden infant death-dysgenesis of the testes syndrome, Sudden infant death-dysgenesis of the testes syndrome, Sudden infant death-dysgenesis of the testes syndrome |
| RS2147819369 | Health Risk | Likely pathogenic | Choroideremia, Choroideremia |
| RS727505368 | Health Risk | Likely pathogenic | Delayed puberty, Delayed puberty |
| RS1567518954 | Health Risk | Pathogenic | Intestinal malrotation, Intestinal malrotation |
| RS1584891562 | Health Risk | Pathogenic | Hypogonadotropic hypogonadism 5 with or without anosmia, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS2144716942 | Health Risk | Pathogenic | Autosomal recessive osteopetrosis 7, Autosomal recessive osteopetrosis 7 |
| RS2521871782 | Health Risk | Pathogenic | 46, XY sex reversal 1, 46 |
| RS2521871783 | Health Risk | Pathogenic | 46, XY sex reversal 1, 46 |
| RS2541435492 | Health Risk | Pathogenic | CHARGE syndrome, CHARGE syndrome |
| RS2544633415 | Health Risk | Pathogenic | Complex cortical dysplasia with other brain malformations 1, Complex cortical dysplasia with other brain malformations 1 |
| RS311103 | Health Risk | Pathogenic | XG BLOOD GROUP SYSTEM, Xg(a-) PHENOTYPE, XG BLOOD GROUP SYSTEM |
| RS483352872 | Health Risk | Pathogenic | Isolated growth hormone deficiency type IB, Isolated growth hormone deficiency type IB |
| RS527236214 | Health Risk | Pathogenic | — |
| RS6548238 | Health Risk | risk factor | Obesity, Obesity |
| RS7138803 | Health Risk | risk factor | Obesity, Obesity |
| RS7711080 | Health Risk | risk factor | Colorectal cancer, Colorectal cancer |
| RS969095 | Health Risk | risk factor | Colorectal cancer, Colorectal cancer |
| RS1800955 | Health Risk | Uncertain risk allele | methamphetamine use disorder, methamphetamine use disorder |
| RS869183622 | Trait | Affects | Venous thromboembolism, Venous thromboembolism |